MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Pioneers: Triple Helix: New Business Models_Open Innovation, Virtual Organizations, Royalty Aggregators, Etc.
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Research Triangle, North Carolina
*Bioscience Regional Clusters & HotSpots
*Industry: Northern California & Silicon Valley
FivePrime Therapeutics
Parents
*Architects: Biotechnology _Monoclonal, Polyclonal, Bispecific Antibodies & Antibody-Drug Conjugates (ADC)s
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
*Industry: California (Biomedical)
*Industry: Northern California & Silicon Valley
*Industry: San Francisco, California
Companies: Acquired_(M&A)
Finance & Acquisitions: Amgen
Children
2021: Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash| Amgen
Dyax, FivePrime Cut Antibody Deal (2011)
FivePrime CEO Julia Gregory (2011)
FivePrime has spent most of its 9-year history building up a vast library of secreted proteins in the body, which attracted big-name investors like Kleiner Perkins Caufield & Byers and a slew of Big Pharma partners like Pfizer, Johnson & Johnson, and Glaxo
FivePrime Nabs $495M Deal With Human Genome Sciences to Develop Cancer Drug (2011)
South San Francisco, California
Jumps
Dyax Corporation (NASDAQ: DYAX)
GlaxoSmithKline plc (GSK)
Human Genome Sciences (NASDAQ: HGSI), #5 (Biotech-Patent Board-2007),
Johnson & Johnson, Inc. [J&J] (NYSE:JNJ)*
Pfizer Inc. (NYSE: PFE)